Stock Earnings

Question 1

What are Lipocine Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Lipocine Inc has a total asset of $22, Net loss of $0

Question 2

What are the key financial ratios for LPCN?

Accepted Answer

Lipocine Inc's Current ratio is 22, has a Net margin is 0, sales per share of $2.02.

Question 3

How is Lipocine Inc's revenue broken down by segment or geography?

Accepted Answer

Lipocine Inc largest revenue segment is Oral Delivery Solutions, at a revenue of 11,198,144 in the most earnings release.For geography, United States is the primary market for Lipocine Inc, at a revenue of 11,198,144.

Question 4

Is Lipocine Inc profitable?

Accepted Answer

no, according to the latest financial statements, Lipocine Inc has a net loss of $0

Question 5

Does Lipocine Inc have any liabilities?

Accepted Answer

yes, Lipocine Inc has liability of 1

Question 6

How many outstanding shares for Lipocine Inc?

Accepted Answer

Lipocine Inc has a total outstanding shares of 5.34

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4	11	-2	0	16	0
Revenue Growth (YoY)	-43%	-650%	--	-100%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	3	5	4	4	5	8
Research & Development	6	7	10	8	7	9
Operating Expenses	10	12	15	12	13	17
Other Non Operating Income (Expenses)	--	0	0	0	0	-2
Pretax Income	-5	0	-16	-10	0	-20
Income Tax Expense	--	0	0	0	0	0
Net Income	-5	0	-16	-10	0	-20
Net Income Growth	25%	-100%	60%	--	-100%	54%
Shares Outstanding (Diluted)	5.41	5.42	5.26	5.23	5.11	3.28
Shares Change (YoY)	1%	3%	1%	2%	56%	115.99%
EPS (Diluted)	-1.01	0	-3.1	-2.06	-0.12	-6.4
EPS Growth	34%	-100%	51%	1,617%	-98%	-25%
Free Cash Flow	-5	-1	-11	-12	-4	-15
Free Cash Flow Per Share	-0.92	-0.18	-2.08	-2.29	-0.78	-4.57
Gross Margin	--	--	--	--	--	--
Operating Margin	-150%	-9.09%	850%	0%	18.75%	0%
Profit Margin	-125%	0%	800%	0%	0%	0%
Free Cash Flow Margin	-125%	-9.09%	550%	0%	-25%	0%
EBITDA	-6	-1	-17	-12	3	-17
EBITDA Margin	-150%	-9.09%	850%	0%	18.75%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-6	-1	-17	-12	3	-17
EBIT Margin	-150%	-9.09%	850%	0%	18.75%	0%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Lipocine Inc (LPCN) Price

LPCN Stock Price Chart

LPCN Income

Follow-Up Questions